The daily business briefing: July 21, 2023
FTX sues to recover money allegedly pilfered by Bankman-Fried and other former executives, NFL owners approve Commanders' sale, and more


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
1. FTX sues to recover money from Bankman-Fried, other former executives
FTX lawyers on Thursday filed a lawsuit in Delaware bankruptcy court accusing company co-founder Sam Bankman-Fried and three members of his leadership team of stealing more than $1 billion shortly before the failed cryptocurrency exchange collapsed last year. The lawyers are trying to recover the allegedly misappropriated funds from the former executives and FTX's trading arm, Alameda Research. The suit claims Bankman-Fried took $10 million he is now using to pay his criminal defense bills by routing it through his Morgan Stanley and TD Ameritrade accounts as a gift to his father, legal scholar Joe Bankman. Caroline Ellison, one of the other executives named in the suit, allegedly paid herself a $22.5 million bonus later used to invest in an artificial intelligence company.
2. NFL team owners approve Washington Commanders sale
NFL team owners on Thursday unanimously approved Josh Harris' $6.05 billion purchase of the Washington Commanders from Daniel Snyder. The record-setting sale could close as soon as Friday. The deal sets up the first change in ownership for the pro football team since Snyder bought it for $800 million from the Jack Kent Cooke estate in 1999. Snyder owned the team for 24 years but never restored the success it had on the field under Cooke's ownership. As part of the sale process, Snyder will pay the NFL $60 million as a result of a league investigation that found he sexually harassed an employee and the Commanders kept some revenue they should have shared with other teams.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Google tests AI journalism tool
Google is testing an artificial-intelligence tool that can use details on current events to produce news stories, according to The New York Times. The company has demonstrated the product, currently called Genesis, to the Times, The Washington Post, and News Corp, which owns The Wall Street Journal. Google co-founder Sergey Brin has returned to Google's Mountain View, California, offices for several days a week in recent month to work with researchers developing the tech giant's next major AI initiative, the Journal reported Thursday. His presence marks a change from the "hands-off approach he adopted after stepping down from an executive role" in 2019, the Journal says.
The New York Times The Wall Street Journal
4. Stock futures rise after Dow extends winning streak
U.S. stock futures rose early Friday after the Dow Jones Industrial Average on Thursday rose for the ninth straight day, its longest winning streak since 2017. Futures tied to the Dow and the S&P 500 were up 0.1% and 0.3%, respectively, at 7 a.m. ET. Nasdaq futures were up 0.5%. Transportation stocks CSX and Knight-Swift fell sharply in pre-market trading after they reported quarterly results that fell short of Wall Street expectations. The Dow gained 0.5% on Thursday but the S&P 500 and the tech-heavy Nasdaq fell 0.7% and 2.1%, respectively, as investors reacted to mixed earnings reports, although 73% of the S&P 500 companies that have reported second-quarter earnings so far have beaten analysts' expectations, according to FactSet.
5. Tornado damage at Pfizer plant could worsen shortages of some drugs
A tornado that damaged a North Carolina Pfizer factory this week could further strain U.S. drug supplies at hospitals, The Associated Press reported Thursday, citing health care industry experts. The tornado tore up the roof of the factory, which makes nearly a quarter of Pfizer's sterile injectable medicines used in U.S. hospitals, the drugmaker said. The plant makes drugs for anesthesia, infection treatment, and use in surgeries and intensive care units for patients on ventilators. The massive plant has 22 packaging lines and 1.4 million square feet of manufacturing space. The damage could result in shortages of some drugs as Pfizer rebuilds or shifts production elsewhere, Erin Fox, senior pharmacy director at University of Utah Health, told AP.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Harold Maass is a contributing editor at TheWeek.com. He has been writing for The Week since the 2001 launch of the U.S. print edition. Harold has worked for a variety of news outlets, including The Miami Herald, Fox News, and ABC News. For several years, he wrote a daily round-up of financial news for The Week and Yahoo Finance. He lives in North Carolina with his wife and two sons.
-
The daily gossip: Hollywood writers and studios reach tentative agreement to end strike, Taylor Swift attends Chiefs game amid Travis Kelce dating rumors, and more
The daily gossip: September 25, 2023
By Brendan Morrow Published
-
Disaster averted
Cartoons
By The Week Staff Published
-
Iran deposit
Cartoons
By The Week Staff Published
-
The daily business briefing: September 25, 2023
Business Briefing Hollywood writers reach deal that would end strike, Canadian autoworkers ratify a new contract with Ford, and more
By Harold Maass Published
-
The daily business briefing: September 22, 2023
Business Briefing Rupert Murdoch steps down as Fox, News Corp. chair, Cisco to buy Splunk in $28 billion cash deal, and more
By Harold Maass Published
-
The daily business briefing: September 21, 2023
Business Briefing The Fed leaves rates unchanged, Biden cancels debts for University of Phoenix borrowers, and more
By Harold Maass Published
-
The daily business briefing: September 20, 2023
Business Briefing Disney says it will invest $60 billion in theme parks, Instacart shares rise in debut, and more
By Harold Maass Published
-
The daily business briefing: September 19, 2023
Business Briefing Instacart prices its shares at top of range in IPO, the UAW threatens to widen its strike, and more
By Harold Maass Published
-
The daily business briefing: September 18, 2023
Business Briefing UAW strike continues after union rejects latest offer, China detains some Evergrande wealth management staff, and more
By Harold Maass Published
-
The daily business briefing: September 15, 2023
Business Briefing United Auto Workers strike against Detroit's Big 3, Arm shares climb in year's biggest IPO, and more
By Harold Maass Published
-
The daily business briefing: September 14, 2023
Business Briefing Surging fuel prices increased August inflation, chipmaker Arm prices its IPO at $51 a share, and more
By Harold Maass Published